Market Cap

Portage Biotech, Inc. Market Capitalization:

$21.6 Million

USD as of Jan. 1, 2024

business Portage Biotech, Inc. Company Profile

Portage Biotech, Inc. Main Stock Listing

NASDAQ: PRTG

Market Capitalization History of Portage Biotech, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Portage Biotech, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $21.6 M -75.94%
Jan. 1, 2023 $89.6 M -37.67%
Jan. 1, 2022 $143.7 M -61.41%
Jan. 1, 2021 $372.4 M 95.57%
Jan. 1, 2020 $190.4 M 27.78%
Jan. 1, 2019 $149.0 M 30.43%
Jan. 1, 2018 $114.3 M -58.18%
Jan. 1, 2017 $273.3 M 60.19%
Jan. 1, 2016 $170.6 M 3.00%
Jan. 1, 2015 $165.6 M -44.44%
Jan. 1, 2014 $298.1 M 45.16%
Jan. 1, 2013 $205.4 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Portage Biotech, Inc. Categories

languages Healthcare languages Biotechnology

Stocks & Indices

Portage Biotech, Inc. has the following listings and related stock indices.


Stock: NASDAQ: PRTG

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.